SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-022764
Filing Date
2022-06-08
Accepted
2022-06-08 16:01:23
Documents
12
Period of Report
2022-06-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K VOTE RESULTS dice-8k_20220607.htm   iXBRL 8-K 46784
  Complete submission text file 0001564590-22-022764.txt   179682

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dice-20220607.xsd EX-101.SCH 5621
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dice-20220607_lab.xml EX-101.LAB 20063
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dice-20220607_pre.xml EX-101.PRE 11958
6 EXTRACTED XBRL INSTANCE DOCUMENT dice-8k_20220607_htm.xml XML 3691
Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40794 | Film No.: 221003463
SIC: 2834 Pharmaceutical Preparations